Table 1.
Patient characteristics of end-stage renal disease (ESRD) samples
| Sample | Conditiona | Genderb | Age (yr) | Comorbiditiesc |
|---|---|---|---|---|
| R1 | Responder | M | 65 | DM + HTN + CAD |
| R2 | Responder | F | 43 | CGN |
| R3 | Responder | F | 66 | HTN + CGN |
| R4 | Responder | M | 62 | DM + HTN |
| NR1 | Non-responder (resistant) | M | 63 | DM + HTN |
| NR2 | Non-responder (resistant) | F | 46 | CGN |
| NR3 | Non-responder (resistant) | F | 61 | HTN + CGN |
aESRD patients’ erythropoietin (EPO) responsiveness. bM, male; F, female. cDiagnosed comorbidities: DM diabetes mellitus, HTN hypertension, CAD coronary artery disease, CGN chronic glomerulonephritis